These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12795242)

  • 21. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of different population pharmacokinetic algorithms.
    Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
    Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
    Mu S; Ludden TM
    J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The estimation of population pharmacokinetic parameters using an EM algorithm.
    Aarons L
    Comput Methods Programs Biomed; 1993 Sep; 41(1):9-16. PubMed ID: 8275683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of nonignorable missing data when modeling unobserved heterogeneity with finite mixture models.
    Lehmann T; Schlattmann P
    Biom J; 2017 Jan; 59(1):159-171. PubMed ID: 27804147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measures of uncertainty of pharmacokinetic and pharmacodynamic parameter estimates: a new computerized algorithm.
    Guzy S; Hunt CA
    Comput Biomed Res; 1996 Dec; 29(6):466-81. PubMed ID: 9012569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of individual and population designs using Splus.
    Retout S; Mentré F
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):417-43. PubMed ID: 15000423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis.
    Yamashita F; Fujita A; Sasa Y; Higuchi Y; Tsuda M; Hashida M
    J Pharm Sci; 2017 Sep; 106(9):2407-2411. PubMed ID: 28450239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian hierarchical model for analyzing multiresponse longitudinal pharmacokinetic data.
    Zhao L; Xia Z
    Stat Med; 2017 Dec; 36(30):4816-4830. PubMed ID: 28960369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check.
    Yano Y; Beal SL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2001 Apr; 28(2):171-92. PubMed ID: 11381569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
    Plock N; Facius A; Hartmann L; Baumann S; Nave R
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):495-508. PubMed ID: 23611571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
    Yates JW
    Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the estimation of the number of dipole sources in EEG source localization.
    Bai X; He B
    Clin Neurophysiol; 2005 Sep; 116(9):2037-43. PubMed ID: 16043395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Two New Robust Parameter Estimation Methods for the Power Function Distribution.
    Shakeel M; Haq MA; Hussain I; Abdulhamid AM; Faisal M
    PLoS One; 2016; 11(8):e0160692. PubMed ID: 27500404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian design criteria: computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model.
    Merlé Y; Mentré F
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):101-25. PubMed ID: 8576840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approximate Bayesian computation (ABC) gives exact results under the assumption of model error.
    Wilkinson RD
    Stat Appl Genet Mol Biol; 2013 May; 12(2):129-41. PubMed ID: 23652634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian parameter estimation and population pharmacokinetics.
    Thomson AH; Whiting B
    Clin Pharmacokinet; 1992 Jun; 22(6):447-67. PubMed ID: 1587057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.